|
Market Closed -
Nasdaq
01:30:00 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.930 USD | -6.98% |
|
-38.51% | -61.84% |
| 24/10 | Avalo Therapeutics Shares Fall After HC Wainwright Downgrade | MT |
| 23/10 | Guggenheim Downgrades Avalo Therapeutics to Neutral From Buy | MT |
| Market Cap | 37Cr 33Cr 31Cr 28Cr 52Cr 3.53TCr 53Cr 368.95Cr 146.07Cr 1.85TCr 139.48Cr 136.51Cr 5.83TCr | P/E 2026 * |
-2.44x | P/E 2027 * | -2.52x |
|---|---|---|---|---|---|
| Enterprise Value | -5.23Cr -4.67Cr -4.32Cr -3.91Cr -7.32Cr -496.9Cr -7.44Cr -52Cr -21Cr -260.34Cr -20Cr -19Cr -820.79Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.31% | Yield 2026 * |
0.16% | Yield 2027 * | 0.01% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AVTX | Delayed | |
CBOE
| AVTX | Real-time | |
|
Tradegate
| C6K0 | Real-time | |
|
Deutsche Boerse AG
| C6K0 | Delayed | |
|
Boerse Muenchen
| C6K0 | Real-time | |
|
Börse Stuttgart
| C6K0 | Delayed |
| 1 day | -6.98% | ||
| 1 week | -38.51% | ||
| Current month | -54.79% | ||
| 1 month | -55.92% | ||
| 3 months | -62.42% | ||
| 6 months | -50.22% | ||
| Current year | -61.84% |
| 1 week | 6.53 |  | 13.18 |
| 1 month | 6.53 | | 15.99 |
| Current year | 6.53 | | 24.27 |
| 1 year | 6.53 | | 24.27 |
| 3 years | 3.39 | | 34.46 |
| 5 years | 3.39 | | 7,055.95 |
| 10 years | 3.39 | | 22,031.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Garry Neil
CEO | Chief Executive Officer | 72 | 14/02/2022 |
| Director of Finance/CFO | 42 | 14/02/2022 | |
Kathleen Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Garry Neil
CHM | Chairman | 72 | 08/08/2022 |
Gilla Kaplan
BRD | Director/Board Member | 78 | 12/10/2020 |
Samantha Truex
BRD | Director/Board Member | 55 | 28/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Free | Director | 1,322 | 0.0025% | ||
| 30/09/26 | Free | Director | 1,109 | 0.0021% | ||
| 30/09/26 | Free | Director | 1,352 | 0.0025% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.98% | -38.51% | -60.56% | -72.94% | 37Cr | |
| +2.41% | +0.29% | +42.02% | +71.57% | 6.47TCr | |
| -0.15% | +7.50% | +11.42% | +71.27% | 5.48TCr | |
| +0.57% | +4.60% | +7.71% | +90.93% | 5.35TCr | |
| +0.37% | +4.67% | +26.68% | +49.64% | 4.6TCr | |
| -1.21% | +2.32% | +21.50% | +118.33% | 4.29TCr | |
| -0.37% | +5.07% | +243.23% | +789.58% | 4.01TCr | |
| +0.05% | +0.21% | +18.06% | +48.50% | 3.35TCr | |
| -0.38% | +5.68% | +38.39% | +28.35% | 2.37TCr | |
| +1.19% | -4.98% | +26.31% | -0.76% | 2.4TCr | |
| Average | -0.45% | -1.68% | +37.48% | +119.45% | 3.83TCr | |
| Weighted average by Cap. | +0.38% | +2.69% | +46.36% | +142.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -11Cr -9.93Cr -9.17Cr -8.31Cr -16Cr -1.06TCr -16Cr -110.4Cr -44Cr -553.1Cr -42Cr -41Cr -1.74TCr | -13Cr -12Cr -11Cr -9.91Cr -19Cr -1.26TCr -19Cr -131.54Cr -52Cr -659.05Cr -50Cr -49Cr -2.08TCr |
| Net Debt | -42Cr -38Cr -35Cr -32Cr -59Cr -4.02TCr -60Cr -420.92Cr -166.64Cr -2.11TCr -159.12Cr -155.74Cr -6.65TCr | -31Cr -27Cr -25Cr -23Cr -43Cr -2.9TCr -43Cr -303.33Cr -120.09Cr -1.52TCr -114.67Cr -112.23Cr -4.79TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $6.930 | -6.98% | 45,51,356 |
| 22/26/22 | $7.450 | -39.23% | 2,61,89,975 |
| 21/26/21 | $12.26 | -0.81% | 9,30,224 |
| 20/26/20 | $12.36 | +6.64% | 18,69,562 |
| 19/26/19 | $11.59 | +2.84% | 22,21,902 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVTX Stock
Select your edition
All financial news and data tailored to specific country editions
